Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Advanced Breast Care
mi
from
Marietta, GA
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Advanced Breast Care
mi
from
Marietta, GA
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Missouri Cancer Associates
mi
from
Columbia, MO
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Missouri Cancer Associates
mi
from
Columbia, MO
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Breast Care
mi
from
Las Vegas, NV
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Breast Care
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Morristown Memorial Hospital
mi
from
Morristown, NJ
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Morristown Memorial Hospital
mi
from
Morristown, NJ
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Beth Israel Med Ctr
mi
from
New York, NY
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Beth Israel Med Ctr
mi
from
New York, NY
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
OU Medical Center
mi
from
Oklahoma City, OK
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
OU Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Willamette Valley Cancer Institute/Research Ctr
mi
from
Eugene, OR
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Willamette Valley Cancer Institute/Research Ctr
mi
from
Eugene, OR
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Breast Care Specialists, P.C.
mi
from
Allentown, PA
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Breast Care Specialists, P.C.
mi
from
Allentown, PA
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Magee-Womens Hospital
mi
from
Pittsburgh, PA
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Magee-Womens Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Women and Infants Hospital of Rhode Island
mi
from
Providence, RI
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Women and Infants Hospital of Rhode Island
mi
from
Providence, RI
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Breast Clinic of Memphis
mi
from
Germantown, TN
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Breast Clinic of Memphis
mi
from
Germantown, TN
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Advantage Clinical Research
mi
from
Nashville, TN
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Advantage Clinical Research
mi
from
Nashville, TN
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Tennessee Breast Specialists
mi
from
Nashville, TN
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Tennessee Breast Specialists
mi
from
Nashville, TN
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Texas Oncology, P.A. - Bedford
mi
from
Bedford, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Texas Oncology, P.A. - Bedford
mi
from
Bedford, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Dallas Surgical Group
mi
from
Dallas, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Dallas Surgical Group
mi
from
Dallas, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Leading Edge Research, PA
mi
from
Dallas, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Leading Edge Research, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Texas Oncology - Dallas Presbyterian Hospital
mi
from
Dallas, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Texas Oncology - Dallas Presbyterian Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Texas Oncology-Baylor Charles A. Sammons Cancer Center
mi
from
Dallas, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Texas Oncology-Baylor Charles A. Sammons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Texas Oncology - Memorial City
mi
from
Houston, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Texas Oncology - Memorial City
mi
from
Houston, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Cancer Care Centers of South Texas
mi
from
San Antonio, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Cancer Care Centers of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Southlake Oncology
mi
from
Southlake, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Southlake Oncology
mi
from
Southlake, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Texas Oncology-Tyler
mi
from
Tyler, TX
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Texas Oncology-Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Virginia Oncology Associates
mi
from
Norfolk, VA
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Virginia Oncology Associates
mi
from
Norfolk, VA
Click here to add this to my saved trials
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated:  12/8/2011
Aurora Sinai Medical Center
mi
from
Milwaukee, WI
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Status: Enrolling
Updated: 12/8/2011
Aurora Sinai Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of PWT33597 Mesylate in Subjects With Advanced Malignancies
A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Orally Administered PWT33597 Mesylate in Subjects With Advanced Malignancies
Status: Enrolling
Updated:  12/13/2011
Pinnacle Hematology Oncology
mi
from
Scottsdale, AZ
Study of PWT33597 Mesylate in Subjects With Advanced Malignancies
A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Orally Administered PWT33597 Mesylate in Subjects With Advanced Malignancies
Status: Enrolling
Updated: 12/13/2011
Pinnacle Hematology Oncology
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study of PWT33597 Mesylate in Subjects With Advanced Malignancies
A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Orally Administered PWT33597 Mesylate in Subjects With Advanced Malignancies
Status: Enrolling
Updated:  12/13/2011
The University of Arizona Cancer Center
mi
from
Tucson, AZ
Study of PWT33597 Mesylate in Subjects With Advanced Malignancies
A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Orally Administered PWT33597 Mesylate in Subjects With Advanced Malignancies
Status: Enrolling
Updated: 12/13/2011
The University of Arizona Cancer Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of PWT33597 Mesylate in Subjects With Advanced Malignancies
A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Orally Administered PWT33597 Mesylate in Subjects With Advanced Malignancies
Status: Enrolling
Updated:  12/13/2011
Dana-Farber Cancer Institute
mi
from
Boston, MA
Study of PWT33597 Mesylate in Subjects With Advanced Malignancies
A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Orally Administered PWT33597 Mesylate in Subjects With Advanced Malignancies
Status: Enrolling
Updated: 12/13/2011
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Study of PWT33597 Mesylate in Subjects With Advanced Malignancies
A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Orally Administered PWT33597 Mesylate in Subjects With Advanced Malignancies
Status: Enrolling
Updated:  12/13/2011
Sarah Cannon Research Institute
mi
from
Nashville, TN
Study of PWT33597 Mesylate in Subjects With Advanced Malignancies
A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Orally Administered PWT33597 Mesylate in Subjects With Advanced Malignancies
Status: Enrolling
Updated: 12/13/2011
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Photoacoustic Endoscopy in Endometrial Cancer
A Pilot Study of Photoacoustic Endoscopy in Endometrial Cancer
Status: Enrolling
Updated:  12/22/2011
Washington University School of Medicine
mi
from
Saint Louis, MO
Photoacoustic Endoscopy in Endometrial Cancer
A Pilot Study of Photoacoustic Endoscopy in Endometrial Cancer
Status: Enrolling
Updated: 12/22/2011
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Cone Beam Computed Tomography for Breast Imaging
Cone Beam Computed Tomography for Breast Imaging and IV Contrast Enhanced Cone Beam Computed Tomography Breast Imaging
Status: Enrolling
Updated:  1/2/2012
Elizabeth Wende Breast Care
mi
from
Rochester, NY
Cone Beam Computed Tomography for Breast Imaging
Cone Beam Computed Tomography for Breast Imaging and IV Contrast Enhanced Cone Beam Computed Tomography Breast Imaging
Status: Enrolling
Updated: 1/2/2012
Elizabeth Wende Breast Care
mi
from
Rochester, NY
Click here to add this to my saved trials
Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1
A Phase I Study of Therapeutic Cancer Vaccine IMF-001 in Patients With Malignancies Expressing NY-ESO-1
Status: Enrolling
Updated:  1/3/2012
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1
A Phase I Study of Therapeutic Cancer Vaccine IMF-001 in Patients With Malignancies Expressing NY-ESO-1
Status: Enrolling
Updated: 1/3/2012
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1
A Phase I Study of Therapeutic Cancer Vaccine IMF-001 in Patients With Malignancies Expressing NY-ESO-1
Status: Enrolling
Updated:  1/3/2012
New York University (NYU) Cancer Center
mi
from
New York, NY
Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1
A Phase I Study of Therapeutic Cancer Vaccine IMF-001 in Patients With Malignancies Expressing NY-ESO-1
Status: Enrolling
Updated: 1/3/2012
New York University (NYU) Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
A Multicentered Randomized Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated:  1/4/2012
University of Alabama at Birmingham
mi
from
Birmingham, AL
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
A Multicentered Randomized Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated: 1/4/2012
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
A Multicentered Randomized Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated:  1/4/2012
UCSF Medical Center
mi
from
San Francisco, CA
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
A Multicentered Randomized Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated: 1/4/2012
UCSF Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
A Multicentered Randomized Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated:  1/4/2012
University of Iowa
mi
from
Iowa City, IA
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
A Multicentered Randomized Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated: 1/4/2012
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
A Multicentered Randomized Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated:  1/4/2012
Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
A Multicentered Randomized Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated: 1/4/2012
Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
A Multicentered Randomized Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated:  1/4/2012
Sanford Health /USD
mi
from
Sioux Falls, SD
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
A Multicentered Randomized Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated: 1/4/2012
Sanford Health /USD
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
A Multicentered Randomized Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated:  1/4/2012
Vanderbilt University
mi
from
Nashville, TN
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
A Multicentered Randomized Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated: 1/4/2012
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
A Multicentered Randomized Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated:  1/4/2012
Eastern Virginia Medical School
mi
from
Norfolk, VA
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
A Multicentered Randomized Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated: 1/4/2012
Eastern Virginia Medical School
mi
from
Norfolk, VA
Click here to add this to my saved trials
Immune Response and Safety of HS110 Vaccine in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer
A Phase 2A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Immune Response, Safety and Efficacy of HS-110 in Combination With Erlotinib vs. Erlotinib as a Single Agent in Patients With Advanced, Non-EGFR Mutated Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  1/4/2012
Mary Crowley Cancer Research Centers
mi
from
Dallas, TX
Immune Response and Safety of HS110 Vaccine in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer
A Phase 2A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Immune Response, Safety and Efficacy of HS-110 in Combination With Erlotinib vs. Erlotinib as a Single Agent in Patients With Advanced, Non-EGFR Mutated Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 1/4/2012
Mary Crowley Cancer Research Centers
mi
from
Dallas, TX
Click here to add this to my saved trials
EMBRACE1: Prostate Biorepository
Evaluation of a Novel Circulating Microvesicle-Based Multi-analyte Assay for the Detection of Prostate Cancer in Men With Elevated Risk for Prostate Cancer; the EMBRACE1 Study
Status: Enrolling
Updated:  1/6/2012
Caris Science, Inc.
mi
from
Phoenix, AZ
EMBRACE1: Prostate Biorepository
Evaluation of a Novel Circulating Microvesicle-Based Multi-analyte Assay for the Detection of Prostate Cancer in Men With Elevated Risk for Prostate Cancer; the EMBRACE1 Study
Status: Enrolling
Updated: 1/6/2012
Caris Science, Inc.
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors
A Dose Escalation, Single Arm, Phase 1b-2 Combination Study of BEZ235 With Everolimus to Determine the Safety, Pharmacodynamics and Pharmacokinetics in Subjects With Advanced Solid Malignancies
Status: Enrolling
Updated:  1/6/2012
University of Cincinnati
mi
from
Cincinnati, OH
Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors
A Dose Escalation, Single Arm, Phase 1b-2 Combination Study of BEZ235 With Everolimus to Determine the Safety, Pharmacodynamics and Pharmacokinetics in Subjects With Advanced Solid Malignancies
Status: Enrolling
Updated: 1/6/2012
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas
Phase I/II Study of Preoperative Gemcitabine in Combination With Oral Hydroxychloroquine (GcHc) in Subjects With High Risk Stage IIb or III Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  1/11/2012
UPCI/UPMC Cancer Centers
mi
from
Pittsburgh, PA
Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas
Phase I/II Study of Preoperative Gemcitabine in Combination With Oral Hydroxychloroquine (GcHc) in Subjects With High Risk Stage IIb or III Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 1/11/2012
UPCI/UPMC Cancer Centers
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer
An Expanded Trial of MC5-A Calmare Therapy in the Treatment of Cancer Pain Syndromes and Chronic Chemotherapy-Induced Peripheral Neuropathy Including Pain and Numbness
Status: Enrolling
Updated:  1/13/2012
Virginia Commonwealth University
mi
from
Richmond, VA
Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer
An Expanded Trial of MC5-A Calmare Therapy in the Treatment of Cancer Pain Syndromes and Chronic Chemotherapy-Induced Peripheral Neuropathy Including Pain and Numbness
Status: Enrolling
Updated: 1/13/2012
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient
The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient
Status: Enrolling
Updated:  1/25/2012
Comprehensive Breast Center at Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient
The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient
Status: Enrolling
Updated: 1/25/2012
Comprehensive Breast Center at Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
Click here to add this to my saved trials
Changes in Brown Adipose Tissue Activity In Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Prospective Study of Changes in Brown Adipose Tissue (BAT) Activity in Men Receiving Androgen Deprivation Therapy (ADT) With a GnRH Agonist or Antagonist for Prostate Cancer
Status: Enrolling
Updated:  1/27/2012
Massachusetts General Hospital
mi
from
Boston, MA
Changes in Brown Adipose Tissue Activity In Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Prospective Study of Changes in Brown Adipose Tissue (BAT) Activity in Men Receiving Androgen Deprivation Therapy (ADT) With a GnRH Agonist or Antagonist for Prostate Cancer
Status: Enrolling
Updated: 1/27/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors
A Multi-Center, Open-Label, Single-Arm, Phase 1, Dose Escalation Study of ASONEP (Sonepcizumab/LT1009) Administered as a Single Agent Weekly to Subjects With Refractory Advanced Solid Tumors
Status: Enrolling
Updated:  1/27/2012
Premiere Oncology
mi
from
Scottsdale, AZ
Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors
A Multi-Center, Open-Label, Single-Arm, Phase 1, Dose Escalation Study of ASONEP (Sonepcizumab/LT1009) Administered as a Single Agent Weekly to Subjects With Refractory Advanced Solid Tumors
Status: Enrolling
Updated: 1/27/2012
Premiere Oncology
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors
A Multi-Center, Open-Label, Single-Arm, Phase 1, Dose Escalation Study of ASONEP (Sonepcizumab/LT1009) Administered as a Single Agent Weekly to Subjects With Refractory Advanced Solid Tumors
Status: Enrolling
Updated:  1/27/2012
Pacific Oncology
mi
from
San Diego, CA
Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors
A Multi-Center, Open-Label, Single-Arm, Phase 1, Dose Escalation Study of ASONEP (Sonepcizumab/LT1009) Administered as a Single Agent Weekly to Subjects With Refractory Advanced Solid Tumors
Status: Enrolling
Updated: 1/27/2012
Pacific Oncology
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors
A Multi-Center, Open-Label, Single-Arm, Phase 1, Dose Escalation Study of ASONEP (Sonepcizumab/LT1009) Administered as a Single Agent Weekly to Subjects With Refractory Advanced Solid Tumors
Status: Enrolling
Updated:  1/27/2012
Premiere Oncology
mi
from
Santa Monica, CA
Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors
A Multi-Center, Open-Label, Single-Arm, Phase 1, Dose Escalation Study of ASONEP (Sonepcizumab/LT1009) Administered as a Single Agent Weekly to Subjects With Refractory Advanced Solid Tumors
Status: Enrolling
Updated: 1/27/2012
Premiere Oncology
mi
from
Santa Monica, CA
Click here to add this to my saved trials